Category Archives: Genetics

Study outlines genetic factors involved in shaping the human gut microbiome – The Mix

The study highlights the common host genetic factors that influence the composition of the human gut microbiome, a major factor in human health.

The study highlights the common host genetic factors that influence the composition of the human gut microbiome, a major factor in human health.Human genes have an impact on shaping our gut ecosystem. A large, international study by the MiBioGen consortium, led by the University Medical Center Groningen, analyzed the common genetic factors that influence the composition of the human gut microbiome in more than 18,000 people. The results were published Jan. 18 in the leading scientific magazine Nature Genetics. Haydeh Payami, Ph.D., professor in the Department of Neurology, University of Alabama at Birmingham, and Zachary Wallen, a postdoctoral fellow in the Payami laboratory, were collaborating authors on the study.

The last decade has greatly expanded our understanding of the human microbiome, the trillions of microbes that inhabit the internal and external surfaces of our bodies, Payami said. We have come to appreciate their vital role in helping proper human development from infancy to adulthood and their active participation in many human functions: helping us to digest food, training our immune system and, importantly, affecting our brain function via the gut-brain axis.

The largest and richest human microbiome inhabits the gut and contributes substantially to our health. Yet the factors that shape its composition, although widely studied, remain unclear, and the more than 80 percent difference in gut microbiome between individuals remains unexplained. In general, environmental factors such as diet and medication play a major role; however, a role for human genetic variants has also been suggested by the identification of heritable bacteria, i.e., those that are more common in twins and family members.

Now, the new study from the MiBioGen consortium, an international collaboration involving more than 20 labs across the world, highlights the common host genetic factors that influence the composition of the human gut microbiome in the more than 18,000 people analysed.

The study says that at least two human genes have a major impact in shaping our gut ecosystem: the lactase gene LCT, which influences the abundance of lactose-digesting Bifidobacteria, and the fucosyl transferase gene FUT2, which determines the abundance of Ruminococcus torques. They also show that other human genes affecting microbiome composition are involved in important aspects of host metabolism, nutrition and immunity. The analyses stretch as far as establishing relationships between several bacterial species and human diseases.

This study is a great example of a large international collaboration and is the first to accurately estimate the effect of host genetics on the gut microbiome, said Alexandra Zhernakova, one of the principal investigators leading the consortium. More genetic effects will likely be identified with increased sample size in future studies, but our multi-center approach did identify robust loci that are shared across populations. However, further studies in large and more homogenous groups are essential to identify population-specific effects and gene-environmental interactions.

Haydeh Payami, Ph.D.It was a challenge to combine datasets from multiple cohorts due to the large technical differences and to biological variations across populations, said Alex Kurilshikov, the first author of the study. However, this diversity also brings strength for example, we could see that genetic variants in the lactase gene determine Bifidobacteria abundance in adults, but not in children, and that this effect is more pronounced in European populations. The large sample size also allowed us to apply genetic methods and show that some bacteria are causal for developing diseases.

The MiBioGen researchers have made their results available to other scientists and the scientific community for additional and future analyses. All results are uploaded to http://mibiogen.org, supported by the Genomics Coordination Center in the Department of Genetics, UMCG.

At UAB, Payamis research focuses on the gut microbiome as a potential missing link between genetic and environmental causes of Parkinsons disease. Her research is supported by a four-year, $2.5 million grant from the U.S. Army Medical Research and Materiel Command.

Previously, Payamis laboratory published findings showing that the composition of the bacteria in the guts of people with Parkinsons disease differed from healthy controls. The researchers also discovered that Parkinsons medications were linked to changes in gut bacteria as well.

The publication in Nature Genetics is available at https://www.nature.com/articles/s41588-020-00763-1.

See the rest here:
Study outlines genetic factors involved in shaping the human gut microbiome - The Mix

Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy -…

SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies. This new collaboration combines Boehringer Ingelheim's experience in disease biology and gene therapy development with Cure Genetics' AAV expertise in library construction and highly efficient in vivo AAV screening. The aim is to provide potential new AAV serotypes for patients.

The clinical applications of existing AAV serotypes are limited by some of their features, such as low transduction efficiency, low tissue specificity and immunogenicity. Therefore, finding new AAV serotypes to overcome these challenges becomes critical for the majority, if not all, AAV-based gene therapies.

Comparing to other traditional vector engineering technologies, Cure Genetics' proprietary VELPTM platform encompasses key methodical innovations, including a comprehensive strategy of engineering a plasmid library with high complexity and an effective ratio. the optimized AAV production protocol ensures high genome-capsid correspondence and world-class production capacity, and the most physiologically relevant models for vector selection and validation. It enables a significantly shorter process to find the "right" AAV vectors with almost all possibility effectively covered.

Boehringer Ingelheim aspires to develop the next generation of medical breakthroughs and gene therapy is one of the focuses under exploration by the team of Research Beyond Borders. The advanced VELPTM technology platform may provide effective solutions in increasing the efficiency of novel AAV screening and help further expand our efforts in the area of gene therapy development.

"This is the very first time that a global pharmaceutical group is collaborating with a Chinese biotech in the cutting-edge field of AAV vector engineering. We appreciate the recognition of Boehringer Ingelheim's recognition of our VELPTM platform. Novel AAV vectors enlarging the therapeutic window is key to unfolding the potential of gene therapy, which is also Cure Genetics' innovative focus . We believe, together with visionary partners like Boehringer Ingelheim, the quality of life for more patients in need can be improved by next-generation gene therapy." stated Dr. Qiushi Li, Cure Genetics' Chief Operating Officer.

The collaboration with Cure Genetics was initiated by Boehringer Ingelheim China External Innovation Hub. It consists of three business units: Research Beyond Borders, Business Development and Licensing, and Venture Fund. The hub is committed to becoming the preferred partner of China's biopharmaceutical industry and bringing more Chinese innovative partnership projects to enrich Boehringer Ingelheim's global R&D pipeline, thereby ultimately benefiting more patients. So far, Boehringer Ingelheim China External Innovation Hub has established various partnerships with reputable research institutions and biotech companies in China.

About Cure Genetics

Cure Genetics is a biotech company founded in 2016, committed to expanding the frontier of gene therapy via its innovative technology of gene editing and gene delivery. With the world-leading AAV manufacturing capability, Cure Genetics' proprietary VELPTM platform enables a fast yet systematic design, selection and optimization of AAV vectors with special features and significantly better performance of in vivo gene delivery, which will empower AAV-based gene therapy to be applied in a much broader range of disease treatments.

SOURCE Boehringer Ingelheim; Cure Genetics

Follow this link:
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy -...

What better way to learn genetics than with gummy bears? – The Takeout

Photo: ANDER GILLENEA / Contributor (Getty Images)

Remember learning about genetics for the first time in biology class? I myself dont remember much, aside from the traumatic time we had to dissect a pregnant rat (I vividly recall the smell of formaldehyde and do not wish to smell it ever again). The only other thing I vaguely remember were those squares we had to fill in. Punnett squares. Remember those? What a pain in the ass. These are two of many reasons why I never became a doctor.

Real genetics are a lot more complicated and dont fall quite so neatly into those Punnett squares, unfortunately. You might think that your genetic composition would be as simple as being an even quarter mix of each of your grandparents blended into one human being. But in reality, processes like genetic recombination shake things up considerably.

Science Alert used gummy bears to show a graphic representation of how genetics can work down the line, inspired by this tweet from NYU neuroscience prof Jay Van Bavel, who tweets as @jayvanbavel:

It is pretty adorable. And delicious. Because who doesnt love the idea of using a handful of gummy bears to depict your ancestry? Its not exactly perfect because, according to Science Alert, gummy bears dont convey dominant or recessive traits (the uppercase letters in a Punnett square are dominant, while the lowercase ones are the recessive ones, if youve forgotten). Still, its something, and in the end, youll be shoving your weirdo genetic mishmash monster gummy bears right into your face; really, there are few things better than a science experiment that you can end up eating later. Plus candy is a great way to get kids (and adults, for that matter) to pay attention. Maybe if wed used them in my biology class, I would be a doctor today.

Read more here:
What better way to learn genetics than with gummy bears? - The Takeout

Study finds genetic variants that increase the risk of bedwetting – News-Medical.net

In a large-scale study of Danish children and young people, researchers from Aarhus University have for the first time found genetic variants that increase the risk of nocturnal enuresis - commonly known as bedwetting or nighttime incontinence. The findings provide completely new insights into the processes in the body causing this widespread phenomenon.

Researchers have long known that nighttime incontinence is a highly heritable condition. Children who wet the bed at night often have siblings or parents who either suffer from or have suffered from the same condition. But until now, science has been unable to pinpoint the genes concerned.

In collaboration with the Danish research project iPSYCH and a team of international colleagues, researchers from Aarhus University have for the first time identified genetic variants that increase the risk of bedwetting. The results have just been published in the scientific journal The Lancet Child & Adolescent Health.

"As many as sixteen per cent of all seven-year-olds suffer from nocturnal enuresis and although many of them grow out of it, one to two per cent of all young adults still have this problem. It is a serious condition, which can negatively affect children's self-esteem and well-being. For example, the children may be afraid of being bullied, and often opt out of events that involve overnight stays," says Jane Hvarregaard Christensen, who is one of the researchers behind the study.

In the study, the researchers studied the genes of 3,900 Danish children and young people, who had either been diagnosed with nocturnal enuresis or had taken medication for it. This group was subsequently compared to 31,000 children and young people who did not suffer from the problem.

We identified two locations in the genome where specific genetic variants increase the risk of bedwetting. The potential causal genes which we point to play roles in relation to ensuring that our brain develops the ability to keep urine production down at night, that the bladder's activity is regulated and registered, and that we sleep in an appropriate way, among other things."

Cecilie Siggaard Jrgensen, Study's First Author

The study also shows that commonly occurring genetic variants can explain up to one-third of the genetic risk of bedwetting. This means that genetic variants which all of us have may lead to involuntary nocturnal enuresis, when they occur in a certain combination.

"But you can still also have all the variants without wetting the bed at night, because there are other risk factors in play that we haven't mapped yet - both genetic and environmental. So it's clear that this is very complex and that it's not possible to talk about a single gene that causes nocturnal enuresis," says Jane Hvarregaard Christensen.

The study also shows that children with many genetic variants that increase the risk of ADHD are particularly vulnerable to developing bedwetting.

"Our findings don't mean that ADHD causes bedwetting in a child, or vice versa, but just that the two conditions have common genetic causes. More research in this area will be able to clarify the details in the biological differences and similarities between the two disorders," she emphasizes.

As the study is a first-time study, the researchers also examined more than 5,500 people from Iceland, where they found that the same genetic variants also appear to increase the risk of nocturnal enuresis.

"This means that we can be more certain that our findings are not coincidental. In the future, we wish to find out whether the same genetic variants increase the risk of bedwetting in children in other parts of the world. Bedwetting is not just an issue in northern European but affects millions of children all over the world," she says.

The researchers hope to be able to further clarify the causes of nocturnal enuresis. It is very likely that it will be possible to identify even more genes and thereby gain a deeper understanding of what is required for a child to become dry at night.

"At present we still can't use a child's genetic profile to predict, for example, whether the child will grow out of its condition or whether a particular treatment works. Perhaps this will be possible in the future when more detailed studies have been conducted," says Jane Hvarregaard Christensen.

The study is a so-called genome-wide association study (GWAS). By examining thousands of genetic variants spread out in the entire genome, a GWAS makes it possible to point to statistically significant correlations between specific genetic variants and nighttime incontinence in the persons who are examined.

The study is a collaboration between researchers at the Department of Biomedicine, Aarhus University and the Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital. Researchers from the Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, and deCODE genetics have also contributed.

Source:

Journal reference:

Jrgensen, C.S.., et al. (2021) Identification of genetic loci associated with nocturnal enuresis: a genome-wide association study. Lancet Child and Adolescent Health. doi.org/10.1016/S2352-4642(20)30350-3.

Read more:
Study finds genetic variants that increase the risk of bedwetting - News-Medical.net

Genetic and Non-genetic Determinants of Cardiovascular Disease in South Asians – DocWire News

This article was originally published here

Curr Diabetes Rev. 2021 Jan 17. doi: 10.2174/1573399817666210118103022. Online ahead of print.

ABSTRACT

South Asians (SAs), people from the Indian subcontinent (e.g. India, Pakistan, Bangladesh, Sri Lanka, and Nepal) have a higher prevalence of cardiovascular disease (CVD) and suffer from a greater risk of CVD-associated mortality compared to other global populations. These problems are compounded by the alterations in lifestyles due to urbanization and changing cultural, social, economic, and political environment. Current methods of CV risk prediction are based on white populations that under-estimate the CVD risk in SAs. Prospective studies are required to obtain actual CVD morbidity/mortality rates so that comparisons between predicted CVD risk can be made with actual events. Overwhelming data support a strong influence of genetic factors. Genome-wide association studies (GWAS) serve as a starting point for future genetic and functional studies since the mechanisms of action by which these associated loci influence CVD is still unclear. It is difficult to predict the potential implication of these findings in clinical settings. This review provides a systematic assessment of the risk factors, genetics, and environmental causes of CV health disparity in SAs, and highlights progress made in clinical and genomics discoveries in the rapidly evolving field which has the potential to show clinical relevance in the near future.

PMID:33461471 | DOI:10.2174/1573399817666210118103022

Read the original here:
Genetic and Non-genetic Determinants of Cardiovascular Disease in South Asians - DocWire News

Discrimination ups anxiety risk regardless of genetics – The Tribune India

New York, January 15

Regardless of genetic risks, exposure to discrimination in life plays a significant role in developing anxiety and related disorders, suggests a new study.

Published in the Proceedings of National Academy of Sciences journal, the study determined that even after controlling genetic risk for anxiety, depression and neuroticism, people reported greater discrimination experiences.

The results demonstrate that discriminatory experiences can potentially cause stress and mental health problems regardless of the genetic constitution of the individual, said researcher Adolfo G Cuevas, an assistant professor at Tufts University in the US.

To gain insight on the connection, the research team used data from a national probability sample of nearly 1,500 non-institutionalised, all English-speaking adults between 25 to 74 years in age. Nearly 49 per cent of the sample were women.

Three self-report scales were used to measure discrimination and other forms of social exclusion, including everyday discrimination, major discrimination and chronic job discrimination.

After accounting for increased genetic liability for anxiety, depression, neuroticism, and other potential genetic and socio-demographic factors, the researchers found a high degree of interdependence between discrimination and anxiety.

The team said the findings demonstrate that alleviating the impact of discrimination has the potential to improve mental health within the overall population. IANS

Here is the original post:
Discrimination ups anxiety risk regardless of genetics - The Tribune India

Free webinar on preserving equine genetics and cloning – Horsetalk

Tullis Matson and Dr Gareth Starbuck with Suffolk Punch mare Ruby and her newborn filly foal, who was born in 2020 through the use of sex-sorted semen.

A free webinar on genetic preservation and animal cloning is being hosted by Tullis Matson next week.

In the first British Breeding webinar for 2021, Matson will talk to Gemini Genetics and ViaGen Pets and Equine to explain the concept and applications of animal genetic preservation and animal regeneration (cloning).

Matson, of Stallion AI Services, will describe the process in submitting samples for genetic preservation and the applications of the technology to not only the equine breeding industry but also to the preservation of rare and endangered breeds and species.

Matson was behind the use of sex-sorting of equine semen that resulted in the birth of a Suffolk Punch filly foal last year. With fewer than 72 female Suffolk Punches remaining in Britain and fewer than 300 in the world, every female born is vital to the survival of this endangered and iconic British horse.

He will then hand over to Blake Russell, president of ViaGen Pets and Equine, for an exclusive insight into the world of animal cloning. Live from their premises in Texas, Canada and South Carolina, this webinar will give behind the scenes access to the extensive facilities and technologies. It will cover everything from companion animal cloning to equine cloning and even rare and endangered species regeneration. A live viewing of the worlds first cloned Przewalskis horse foal is also on the agenda.

Pre-registration is essential. Those booking will receive a link and access code for the webinar.

Register for the webinar, on Thursday, January 28 at 7pm (GMT)

Blake Russell is President @ViaGen Pets and Equine, which deliver genetic preservation and cloning services to pet and horse owners worldwide. He also runs an equine breeding program at his ranch in North Texas, where he and his family take care of his prized cloned stallion Pure Tailor Fit, a clone of two-time AQHA Racing World Champion Tailor Fit. Blake has had a successful 25-year career in the animal genetics business working in more than 15 countries. He received his B.S. in Animal Science from Oklahoma State University and his MBA from Emory University.

Tullis Matson is Founder and Managing Director @Stallion AI Services. He began working in racing stables and then running his fathers non-thoroughbred stud at Twemlows Hall, before a study tour of New Zealand where he completed a course on the Artificial Insemination (AI) of horses. On his return, Twemlows Hall Stud Farm began practising AI for the first time. Tullis started Stallion AI Services Ltd in 1996 and this soon developed into taking stallions in for freezing, chilling and fresh insemination. In 2008, Tullis set up Equine Reproduction Supplies which is now the UKs largest distributor of equine artificial insemination equipment and in 2010 was given the exclusive rights to distribute the world-renowned Minitube products in the UK. In 2011 Tullis Matson received the Marsh Christian Award for Conservation in Genetic Bio-Diversity, in recognition of significant technical, scientific and practical contributions to the field of genetic bio-diversity.

Go here to read the rest:
Free webinar on preserving equine genetics and cloning - Horsetalk

Twins with Covid-19 help scientists untangle the diseases genetic roots. – The New York Times

Kimberly and Kelly Standard, who are twins, assumed that when they became sick with Covid-19 their experiences would be as identical as their DNA.

The virus had different plans.

Early last spring, the sisters from Rochester, Mich., checked themselves into the hospital with fevers and shortness of breath. While Kelly was discharged after less than a week, her sister ended up in intensive care, and spent almost a month in critical condition.

Nearly a year later, the sisters are bedeviled by the divergent paths their illnesses took.

I want to know, Kelly said, why did she have Covid worse than me?

Identical twins offer a ready-made experiment to untangle the contributions of nature and nurture in driving disease. With the help of twin registries in the United States, Australia, Europe and elsewhere, researchers are confirming that genetics can influence which symptoms Covid-19 patients experience.

These studies have also underscored the importance of the environment and pure chance: Even between identical twins, immune systems can look vastly different.

But at least some of the factors that influence the severity of a Covid-19 case are written into the genome. Recent studies suggest that people with type O blood, for example, may be at a slightly lower risk of becoming seriously sick (though experts have cautioned against overinterpreting these types of findings). Other papers have homed in on genes that affect how cells sound the alarm about viruses.

There even seems to be a measurable genetic influence on whether patients experience symptoms like fever, fatigue and delirium, said Tim Spector, an epidemiologist and the director of the TwinsUK registry based at St. Thomas Hospital in London.

Last year, he and his colleagues developed a symptom-tracking app. In a study that has not yet been published in a scientific journal, they reported that genetic factors might account for up to 50 percent of the differences between Covid-19 symptoms.

Still, Dr. Spector said, It would be wrong to think we can answer this if we just crack the genes.

Read this article:
Twins with Covid-19 help scientists untangle the diseases genetic roots. - The New York Times

Discrimination may increase risk of anxiety disorders regardless of genetics, study finds – Tufts Now

MEDFORD/SOMERVILLE, Mass (Jan. 14, 2021) Exposure to discrimination plays a significant role in the risk of developing anxiety and related disorders, even in a first after accounting for potential genetic risks, according to a multidisciplinary team of health researchers led by Tufts University and the Harvard T.H. Chan School of Public Health.

Researchers determined that even after controlling for genetic risk for anxiety, depression, and neuroticism, greater reports of discrimination experiences remained associated with higher scores of anxiety and related disorders. The findings, recently published in Proceedings of the National Academy of Sciences, suggest that discrimination is a risk factor for anxiety and related disorders rather than solely a result of common genetic liability.

The study authors included researchers from Stony Brook University, University of Minnesota, in addition to Harvards School of Public Health and Tufts.

The study results demonstrate that discriminatory experiences can potentially cause stress and mental health problems regardless of the genetic constitution of the individual, said Adolfo G. Cuevas, an assistant professor of community health and director of the Psychosocial Determinants of Health Lab at Tufts School of Arts and Sciences, who is first author of the study. From regular slights in public spaces to more significant incidents, such as being passed over for a promotion or a loan, these experiences can take a toll on your mental health.

Anxiety disorders, including generalized anxiety disorder, panic disorder or phobias, are the most common mental illness, affecting over 40 million people in the United States every year, according to the Anxiety and Depression Association of America. While exposure to discrimination has long been established as a risk factor in the development of these disorders, the relationship between discrimination and anxiety, when factoring in the role genetics play, has remained less clear.

To gain insight on the connection, the research team used data from a national probability sample of approximately 1,500 non-institutionalized, all English-speaking adults aged 2574 and living in the mainland United States. Approximately 49 percent of the sample were women.

Three self-report scales were used to measure discrimination and other forms of social exclusion, including:

After accounting for increased genetic liability for anxiety, depression, neuroticism, and other potential genetic and sociodemographic factors, the researchers found a high degree of interdependence between discrimination and anxiety.

The team said the findings demonstrate that alleviating the impact of discrimination has the potential to improve mental health within the overall population. "Anxiety is one of the most significant issues in mental health today, and our study conclusions underscore the importance of reducing discrimination exposure and thereby improving the public's mental health overall," said the senior author of the study, Robert F. Krueger, Distinguished McKnight University Professor of Psychology at the University of Minnesota.

These findings allow us to engage in conversations with political leaders, health officials, and community members to develop functional approaches to reduce exposure to discrimination and improve the mental health of all, David R. Williams, a study co-author and theFlorence Sprague Norman and Laura Smart Norman Professor of Public Health at the Harvard T.H. Chan School of Public Health. Williams is also a professor in the department of African and African American Studies at Harvard.

The impact of anxiety disorders is significant. Symptoms are a common associated feature of depressive disorders and, generally, account for a substantial burden of morbidity and mortality as well as long-term work disability and absenteeism. For instance, anxiety disorders are associated with several chronic health conditions, including heart disease, hypertension, and diabetes.

The researchers identified key limitations of the study, including the use of a cohort of white-identifying respondents who were predominately of European ancestry. They noted while the effects of discrimination seem to be similar across racial/ethnic groups, racial/ethnic minorities experience more discrimination than their white counterparts, placing them at an increased risk for poor mental health. In addition, questions remain about the extent to which self-reported experiences of discrimination by whites are equivalent to those of more socially stigmatized groups.

The study uses data from the MIDUS (the study of Midlife in the United States Biomarker) study, which is supported by the John D. and Catherine T. MacArthur Foundation Research Network, National Institute on Aging and other funders. The development of the manuscript was partially supported by Cancer Disparities Research Network/Geographic Management Program and other supporters. See the paper for detailed information on all funders.

Cuevas, A.G., Mann, F.D., Williams, D.R., and Krueger, R. F. (2020), Discrimination and anxiety: Using multiple polygenic scores to control for genetic liability, PNAS. DOI: 20172244118

###

About Tufts University

Tufts University, located on campuses in Boston, Medford/Somerville and Grafton, Massachusetts, and in Talloires, France, is recognized among the premier research universities in the United States. Tufts enjoys a global reputation for academic excellence and for the preparation of students as leaders in a wide range of professions. A growing number of innovative teaching and research initiatives span all Tufts campuses, and collaboration among the faculty and students in the undergraduate, graduate and professional programs across the university's schools is widely encouraged.

Read this article:
Discrimination may increase risk of anxiety disorders regardless of genetics, study finds - Tufts Now

Programmable genetics gets more cash as Tessera Therapeutics gets a $230 million infusion – TechCrunch

Technologists are getting better at coding biology and venture firms are flooding a new generation of startups with cash so they can commercialize their technology bringing in the next wave of genetic innovation.

Tessera Therapeutics, the Boston-based spin-up from Flagship Pioneering, is the latest company to enter the mix with $230 million in new financing to build up its platform for better biological programming.

The round was led by Alaska Permanent Fund Corp., Altitude Life Science Ventures and the second SoftBank Vision Fund, with participation from the Qatari Investment Authority and other undisclosed investors.

Last year, the company took the covers off its gene-writing service, which combined an array of different gene editing, manufacturing and synthesizing technologies to provide more tailored therapeutic instructions to genetic code.

By providing more instructions to genetic material, the company aims to increase the precision of therapies while expanding the number of potential pathogens or mutations they can target, the company said in a statement.

The thesis is similar to the approach taken by companies like Senti Bio, another early-stage biotech company that raised $105 million earlier this month.

The ability to write in the code of life will be a defining technology of this century and drive a fundamental change in medicine. Todays support is a testament to Tesseras outstanding team of scientists and our focus on bringing the extraordinary promise of Gene Writing to patients, said Geoffrey von Maltzahn, CEO and co-founder of Tessera Therapeutics, and a partner at Flagship Pioneering. We look forward to turning this powerful technology into a new category of medicines.

Part of a number of companies focused on gene therapies and gene-editing technologies that have been developed under the Flagship Pioneering umbrella, Tessera Therapeutics focuses on the development of new therapies that will use messenger RNA, targeted fusogenic vectors and epigenetic controllers, according to Flagship Pioneering founder and chief executive Noubar Afeyan, who also serves as the chair and co-founder of Tessera.

While Senti Bio is adding more programming to existing genetic material, Tessera uses mobile genetic elements, the most abundant genetic material in the body to create new vectors for writing and rewriting the human genome.

The company asserts that this represents a breakthrough in genetic engineering, which can build better therapies. Thats because the technology can target very specific sites in the genome to make any substitutions, insertions or deletions in genetic code. Tessera also said that its tech allows for more efficient engineering of somatic cell genomes without double stranded-breaks and with very little reliance on DNA repair pathways.

Gene writing is inspired by and builds upon the shoulders of natures most prevalent class of genes: mobile genetic elements. Tesseras computational and high-throughput laboratory platform has enabled the team to design, build and test thousands of engineered and synthetic mobile genetic elements for writing and rewriting the human genome.

The company said it can also write entirely new sequences into the genome by delivering only RNA.

With the new round of funding, Tessera said it would look to further develop its tech, hire more staff and establish manufacturing and automation capabilities critical for its platform and programs.

Follow this link:
Programmable genetics gets more cash as Tessera Therapeutics gets a $230 million infusion - TechCrunch